NICE recommends venetoclax plus rituximab for adults with CLL . . .
- 4 Downloads
- 1.NICE. Thousands of adults with chronic lymphocytic leukaemia to benefit from new treatment option. Internet Document : 18 Jan 2019. Available from: URL: https://www.nice.org.uk/news/article/thousands-of-adults-with-chronic-lymphocytic-leukaemia-to-benefit-from-new-treatment-option
- 2.NICE. New migraine drug not cost-effective NICE says in draft guidance Internet Document : 10 Jan 2019. Available from: URL: https://www.nice.org.uk/news/article/new-migraine-drug-not-cost-effective-nice-says-in-draft-guidance
© Springer Nature Switzerland AG 2019